MAY 08, 2022 11:44 AM PDT

A Relative of Some of the World's Deadliest Viruses is Found in Europe

WRITTEN BY: Carmen Leitch

African fruit bats are the natural hosts of Marburg and Ebola viruses, both of which are filoviruses. These RNA viruses are zoonotic - they can cross the species barrier and infect people, and they are also known and feared for their pathogenicity. Now researchers have isolated another filovirus called Lloviu virus (LLOV). The research has shown that LLOV can infect people. This study, which was reported in Nature Communications, has highlighted the importance of preparing for future pandemics.

An electron microscopic image of an isolate of Marburg virus, which is similar in morphology to Ebola virus.  / Credit: CDC/ Dr. Frederick Murphy

There is debate about whether bats or rodents tend to harbor viruses that can infect humans, or whether they are unexceptional and don't harbor anymore zoonotic viruses than other species. But in the case of LLOV, genetic material that indicates the presence of the virus has been revealed in bats in Spain and Hungary.

While human LLOV infections have not yet been reported, our population continues to grow around the world, and our settlements have extended, sometimes deeply into the natural habitats of many animals. Our connections to the many animals used in agriculture also remain close. We don't have a robust repository of antiviral medications, and public health officials have warned about the potential for viral disease to spread. Other microbes with pathogenic potential like bacteria and fungi also remain threats.

Now that we know that LLOV can infect and replicate in human cells, we know that it will be important to watch for the virus. The researchers have stressed that additional research should be performed so we can learn more about how LLOV could spread, and what antibodies might be useful against it. The study has also shown that even though Ebola is a filovirus, antibodies against Ebolavirus are ineffective against LLOV, so Ebola vaccines would probably not be useful for protecting people from LLOV.

This study is "a smoking gun. It's vital that we know both more about the distribution of this virus and that research is done in this area to assess the risks and to ensure we are prepared for potential epidemics and pandemics," noted Dr. Simon Scott of the Medway School of Pharmacy.

Importantly, we know now we have a knowledge gap when it comes LLOV, and potentially other viruses as well. Researchers are aiming to address that problem; a consortium based in Europe now wants to know more about whether LLOV poses a threat to people. They also want to know more about other viruses that animals (including bats) in Europe may be hosting, and whether those viruses, such as coronaviruses, could be transmitted to people.

Sources: University of Kent, Nature Communications

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 29, 2022
Microbiology
Changes in the Mouth Bacteria of Depressed College Students
AUG 29, 2022
Changes in the Mouth Bacteria of Depressed College Students
The microbes in our bodies can have a significant influence on our health and well-being. While many studies investigati ...
SEP 08, 2022
Microbiology
Sir Ronald Ross- A Scientific Pioneer
SEP 08, 2022
Sir Ronald Ross- A Scientific Pioneer
In the 19th century Sir Ronald Ross, a soldier, pioneer, microbiologist, botanist, and a knight helped shape how we view ...
SEP 11, 2022
Plants & Animals
Potential Treatment for Chagas Disease
SEP 11, 2022
Potential Treatment for Chagas Disease
Chagas disease is a condition caused by a parasitic infection; specifically, the parasite Trypanosoma cruzi (T. cruzi), ...
SEP 26, 2022
Drug Discovery & Development
Respiratory Syncytial Virus Antigens and Antibodies
SEP 26, 2022
Respiratory Syncytial Virus Antigens and Antibodies
In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial v ...
OCT 21, 2022
Coronavirus
Recognizing the Importance of SARS-CoV-2 'Accessory' Genes
OCT 21, 2022
Recognizing the Importance of SARS-CoV-2 'Accessory' Genes
The genome of the virus that causes COVID-19, SARS-CoV-2, is very small. But it encodes for more than just the spike pro ...
NOV 30, 2022
Drug Discovery & Development
Saying "Bye" to UTI E. Coli
NOV 30, 2022
Saying "Bye" to UTI E. Coli
In the arms race between animal and bacteria, endogenous antimicrobial peptides (AMPs) are our body’s way of defen ...
Loading Comments...